Outcomes of NSCLC patients with positive EGFR mutation

被引：0
|
作者：
Diver, Sarah
Haris, Mohammed
Khan, Shahul Leyakathali
Kerr, Jane
Edwards, Jane
Munavvar, Mohammed
机构：
[1] Royal Preston Hosp, Med, Preston PR2 9HT, Lancs, England
[2] Royal Preston Hosp, Resp Med, Preston PR2 9HT, Lancs, England
[3] Royal Preston Hosp, Pathol, Preston PR2 9HT, Lancs, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Lung cancer / Oncology;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3269
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Development of a Fluorinated Analogue of Erlotinib for PET Imaging of EGFR Mutation–Positive NSCLC
    Ofer Shamni
    Hilbert Grievink
    Batel Itamar
    Eyal Mishani
    Galith Abourbeh
    Molecular Imaging and Biology, 2019, 21 : 696 - 704
  • [42] Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs
    Zhu, Yan-juan
    Zhang, Hai-bo
    Liu, Yi-hong
    Zhang, Fu-li
    Zhu, Ya-zhen
    Li, Yong
    Bai, Jian-ping
    Liu, Li-rong
    Qu, Yan-chun
    Qu, Xin
    Chen, Xian
    Li, Yan
    Zheng, Guang-juan
    ONCOTARGET, 2017, 8 (08) : 13195 - 13205
  • [43] Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings
    Harvey, R. Donald
    Adams, Val R.
    Beardslee, Tyler
    Medina, Patrick
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (06) : 1461 - 1474
  • [44] Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
    Yvette N. Lamb
    Targeted Oncology, 2021, 16 : 687 - 695
  • [45] Tracking Progression of EGFR Mutation Positive NSCLC From Blood: Is This the Prime Time?
    Liu, Si-Yang Maggie
    Li, Molly Siu Ching
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (11) : 1482 - 1485
  • [46] CNS Metastases in EGFR Mutation Positive NSCLC: Impact on Health Resource Utilization
    Chooback, N.
    Lefresne, S.
    Lau, S.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2205 - S2205
  • [47] Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
    Lamb, Yvette N.
    TARGETED ONCOLOGY, 2021, 16 (05) : 687 - 695
  • [48] Postoperative prognosis in patients with NSCLC with different EGFR mutation sites
    Dong, Chao
    Zhang, Hushan
    Liu, Weiqing
    Kong, Deyu
    Chen, Xiao
    Mo, Fei
    Deng, Jun
    Qian, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC
    Thongprasert, S.
    Geater, S. L.
    Clement, D.
    Abdelaziz, A.
    Reyes-Igama, J.
    Jovanovic, D.
    Alexandru, A.
    Schenker, M.
    Sriuranpong, V.
    Serwatowski, P.
    Suresh, S.
    Cseh, A.
    Gaafar, R.
    ANNALS OF ONCOLOGY, 2018, 29 : 146 - 146
  • [50] EGFR MUTATION AND OUTCOMES IN PATIENTS WITH METASTATIC NSCLC TREATED WITH ERLOTINIB AT INSTITUTO ONCOLOGICO NACIONAL. PANAMA
    Castillo-Fernandez, Omar
    Arauz, Erick
    Cabreja, Angela
    Loo, Yong
    Veliz, Ignacio
    Guardia, Mario
    Rodriguez, Ivette
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S189 - S189
12345